Financhill
Back

Regenxbio Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Sell
29

RGNX
Regenxbio

Last Price:
12.49
Seasonality Move:
5.39%
Sell
49

CPRX
Catalyst Pharmaceuticals

Last Price:
21.34
Seasonality Move:
-9.09%
Sell
29
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $12.50. The Score for RGNX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.36. The Score for CPRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $12.50
    The current trend is relatively stagnant and RGNX is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 52.77 Buy
Chaikin Money Flow: -575220 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.58 - 12.56) Buy
Bollinger Bands (100): (11.56 - 14.94) Sell

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.5 Buy
Relative Strength Index (14 RSI): 70.42 Buy
Chaikin Money Flow: 901932 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.72 - 20.62) Buy
Bollinger Bands (100): (15.22 - 19.16) Buy

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.53 Sell
20-day SMA: 12.03 Buy
50-day SMA: 12.54 Sell
200-day SMA: 15.68 Sell
8-day EMA: 12.46 Buy
20-day EMA: 12.26 Buy
50-day EMA: 12.51 Sell
200-day EMA: 15 Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.25 Buy
20-day SMA: 20.17 Buy
50-day SMA: 18.73 Buy
200-day SMA: 16.16 Buy
8-day EMA: 20.45 Buy
20-day EMA: 20.02 Buy
50-day EMA: 18.92 Buy
200-day EMA: 16.55 Buy

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.42 per share, an increase next quarter of $0.03 per share, an increase this year of $1.03 per share, and an increase next year of $3.83 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):